These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 3102669)

  • 1. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I--directed cytotoxicity.
    Aparicio P; Jaraquemada D; López de Castro JA
    J Exp Med; 1987 Feb; 165(2):428-43. PubMed ID: 3102669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities.
    Reinsmoen NL; Bach FH
    Hum Immunol; 1986 Aug; 16(4):329-46. PubMed ID: 2428780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
    Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
    J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine specificity of HLA-B27 cellular allorecognition. HLA-B27f is a functional variant distinguishable by cytolytic T cell clones.
    Aparicio P; Rojo S; Jaraquemada D; López de Castro JA
    J Immunol; 1987 Aug; 139(3):837-41. PubMed ID: 2439595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition.
    Aparicio P; Vega MA; López de Castro JA
    J Immunol; 1985 Nov; 135(5):3074-81. PubMed ID: 2413111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma cell lysis by human CTL clones: differential involvement of T3, T8 and HLA antigens.
    Fossati G; Anichini A; Parmiani G
    Int J Cancer; 1987 Jun; 39(6):689-94. PubMed ID: 3108167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic human HLA class II restricted purified protein derivative-reactive T-lymphocyte clones. IV. Analysis of HLA restriction pattern and mycobacterial antigen specificity.
    Hansen PW; Petersen CM; Povlsen JV; Kristensen T
    Scand J Immunol; 1987 Mar; 25(3):295-303. PubMed ID: 3494302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 is involved in both class I- and class II-induced proliferation of a cytolytic T-cell clone with dual specificity for HLA-B27 and HLA-DR2 antigens.
    Aparicio P; López de Castro JA
    Hum Immunol; 1989 Apr; 24(4):295-9. PubMed ID: 2496053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and anti-T3-(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones.
    Van Seventer GA; Van Lier RA; Spits H; Ivanyi P; Melief CJ
    Eur J Immunol; 1986 Nov; 16(11):1363-71. PubMed ID: 2430810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity.
    Dohlsten M; Hedlund G; Lando PA; Trowsdale J; Altmann D; Patarroyo M; Fischer H; Kalland T
    Eur J Immunol; 1991 Jan; 21(1):131-5. PubMed ID: 1671356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell clonal analysis of HLA-DR2 haplotypes.
    Reinsmoen NL; Bach FH
    Hum Immunol; 1987 Sep; 20(1):13-31. PubMed ID: 3316134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal heterogeneity of HLA-B27 cellular allorecognition. Delineation of immunodominant sites.
    Aparicio P; Jaraquemada D; Rojo S; López de Castro JA
    Eur J Immunol; 1988 Feb; 18(2):203-9. PubMed ID: 2450755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell binding.
    Biddison WE; Rao PE; Talle MA; Goldstein G; Shaw S
    J Exp Med; 1984 Mar; 159(3):783-97. PubMed ID: 6199452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
    Van Seventer GA; Van Lier RA; Kuijpers KC; Spits H; Melief CJ
    Eur J Immunol; 1988 Dec; 18(12):1973-8. PubMed ID: 2905994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
    Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
    Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.